Summary
AVG Chart
Avantor Stock Plunges as Q3 Earnings Miss Estimates, Revenues Down Y/Y
AVTR's Q3 earnings and revenue fell short of estimates, leading the company to cut its full-year 2025 outlook.
Avantor, Inc. (AVTR) Q3 2025 Earnings Call Transcript
Avantor, Inc. ( AVTR ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants Allison Hosak - Senior VP of Global Communications & Brand Emmanuel Ligner - President & CEO R. Jones - Executive VP & CFO Conference Call Participants Vijay Kumar - Evercore ISI Institutional Equities, Research Division Michael Ryskin - BofA Securities, Research Division Daniel Brennan - TD Cowen, Research Division Luke Sergott - Barclays Bank PLC, Research Division Tycho Peterson - Jefferies LLC, Research Division Patrick Donnelly - Citigroup Inc., Research Division Douglas Schenkel - Wolfe Research, LLC Daniel Leonard - UBS Investment Bank, Research Division Presentation Operator Good morning.
Compared to Estimates, Avantor (AVTR) Q3 Earnings: A Look at Key Metrics
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Avantor Inc. (AVG) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Avantor Inc. ever had a stock split?
Avantor Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Emmanuel Ligner CEO | XFRA Exchange | US05352A1007 ISIN |
| US Country | 13,500 Employees | - Last Dividend | - Last Split | 17 May 2019 IPO Date |
Overview
Avantor, Inc. is a global provider known for offering critical products and services across various industries, including biopharma, healthcare, education and government, as well as advanced technologies and applied material sectors. With a rich history dating back to 1904, Avantor operates in the Americas, Europe, Asia, the Middle East, and Africa. Positioned as an essential partner for its clients, Avantor's support is pivotal in the fields of scientific research, healthcare, and manufacturing, among others. The company maintains its headquarters in Radnor, Pennsylvania, underlining its long-standing commitment to excellence and innovation in serving its customers' needs.
Products and Services
Materials and Consumables: These include high-purity chemicals and reagents, lab products, and supplies aimed at various research and development applications. Avantor also specializes in formulated silicone materials, customized excipients (substances added to drugs to support the active ingredients), and single-use assemblies tailored to specific projects. Further offerings encompass process chromatography resins and columns, analytical sample preparation kits, education and microbiology products, clinical trial kits, and peristaltic pumps along with fluid handling tips. These products are essential for customers involved in scientific research and manufacturing processes.
Equipment and Instrumentation: Avantor provides a range of vital equipment such as filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and supplies for critical environments. This equipment is crucial for maintaining precise conditions in laboratories and manufacturing settings, ensuring the integrity and accuracy of experiments and products.
Services and Specialty Procurements: The company's service offerings include onsite lab and production support, clinical services, equipment services, procurement and sourcing solutions, and biopharmaceutical material scale-up and development services. Avantor's expertise extends to providing scientific research support services, including DNA extraction, bioreactor servicing, clinical and biorepository services, and compound management. These services enable clients to optimize their operations, manage costs, and accelerate the development of new products and therapies.
Contact Information
